NAD+ (lithium)

• Description :

  NAD+ lithium (β-DPN lithium) is a lithium salt of nicotinamide adenine dinucleotide. NAD+ is a coenzyme in the REDOX reaction. NAD+ can directly or indirectly affect several key cellular functions, including metabolic pathways, DNA repair, chromatin remodeling, cell aging, and immune cell function[1].

• Product Name Alternative :

  β-DPN (lithium) ; β-NAD (lithium) ; β-Nicotinamide Adenine Dinucleotide (lithium)

• UNSPSC :

  12352200

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Biochemical Assay Reagents

• Type :

  Biochemical Assay Reagents

• Related Pathways :

  Others

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/nad-lithium.html

• Purity :

  98.77

• Solubility :

  H2O : 100 mg/mL (ultrasonic)

• Smiles :

  O[C@H]1[C@@H](O[C@@H]([C@H]1O)COP(OP(OC[C@H]2O[C@@H]([N+]3=CC=CC(C(N)=O)=C3)[C@@H]([C@@H]2O)O)([O-])=O)(O[Li])=O)N4C5=NC=NC(N)=C5N=C4

• Molecular Formula :

  C21H26LiN7O14P2

• Molecular Weight :

  669.36

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021 Feb;22 (2) :119-141.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Biochemical Assay Reagents

• Clinical Information :

  Phase 2

• CAS Number :

  [64417-72-7]